Search

everythinglearnresearchcommunity

for

Search:↓

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Low testosterone levels may contribute to female pattern hair loss in men.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

The new Follicular Map method could help assess hair treatment effectiveness but has some limitations.

Normal hair thickness varies by scalp area and a mix of hair thicknesses is typical in healthy individuals.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Platelet-rich plasma (PRP) is a cheap and easy treatment for hair loss, but not suitable for everyone. It also helps in healing ulcers, rejuvenating skin, and improving hair transplants.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Reflectance confocal microscopy can help tell apart scarring from non-scarring hair loss.

BTA safely and effectively treats hair loss, and works better with FNS.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Human hair varies widely and should be classified by curl type rather than race.

Different hair loss types need accurate diagnosis for proper treatment.

Ciproterone acetate improves hair regrowth and acne in most female patients.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Combination therapy promotes better hair growth and density.